{"id":"https://openalex.org/W2152306751","doi":"https://doi.org/10.7164/antibiotics.57.260","title":"FR171456, a Novel Cholesterol Synthesis Inhibitor Produced by Sporormiella minima No. 15604: II. Biological Activities","display_name":"FR171456, a Novel Cholesterol Synthesis Inhibitor Produced by Sporormiella minima No. 15604: II. Biological Activities","publication_year":2004,"publication_date":"2004-01-01","ids":{"openalex":"https://openalex.org/W2152306751","doi":"https://doi.org/10.7164/antibiotics.57.260","mag":"2152306751","pmid":"https://pubmed.ncbi.nlm.nih.gov/15217190"},"language":"en","primary_location":{"id":"doi:10.7164/antibiotics.57.260","doi":"https://doi.org/10.7164/antibiotics.57.260","is_oa":true,"landing_page_url":"https://doi.org/10.7164/antibiotics.57.260","pdf_url":"https://www.jstage.jst.go.jp/article/antibiotics1968/57/4/57_4_260/_pdf","source":{"id":"https://openalex.org/S154771817","display_name":"The Journal of Antibiotics","issn_l":"0021-8820","issn":["0021-8820","1881-1469"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Antibiotics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.jstage.jst.go.jp/article/antibiotics1968/57/4/57_4_260/_pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5021304372","display_name":"Hidetaka Hatori","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"HIDETAKA HATORI","raw_affiliation_strings":["Exploratory Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., 5-2-3 Tokodai, Tsukuba, Ibaraki 300-2698, Japan. hidetaka_hatori@po.fujisawa.co.jp","Exploratory Research Laboratories, Fujisawa Pharmaceutical Co., Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Exploratory Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., 5-2-3 Tokodai, Tsukuba, Ibaraki 300-2698, Japan. hidetaka_hatori@po.fujisawa.co.jp","institution_ids":[]},{"raw_affiliation_string":"Exploratory Research Laboratories, Fujisawa Pharmaceutical Co., Ltd","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033632550","display_name":"Toshihiro Shibata","orcid":"https://orcid.org/0000-0002-2065-9385","observed_orcids":["https://orcid.org/0000-0002-2065-9385"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"TOSHIHIRO SHIBATA","raw_affiliation_strings":["Research Planning, Research Division, Fujisawa Pharmaceutical Co., Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Planning, Research Division, Fujisawa Pharmaceutical Co., Ltd","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113984737","display_name":"MOTOAKI NISHIKAWA","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"MOTOAKI NISHIKAWA","raw_affiliation_strings":["PMD Research Centor, Fujisawa Pharmaceutical Co., Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PMD Research Centor, Fujisawa Pharmaceutical Co., Ltd","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029098844","display_name":"Hirotsugu Ueda","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"HIROTSUGU UEDA","raw_affiliation_strings":["Exploratory Research Laboratories, Fujisawa Pharmaceutical Co., Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Exploratory Research Laboratories, Fujisawa Pharmaceutical Co., Ltd","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014183884","display_name":"Motohiro Hino","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"MOTOHIRO HINO","raw_affiliation_strings":["Exploratory Research Laboratories, Fujisawa Pharmaceutical Co., Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Exploratory Research Laboratories, Fujisawa Pharmaceutical Co., Ltd","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110767201","display_name":"Takashi Fujii","orcid":"https://orcid.org/0000-0002-0997-3365","observed_orcids":["https://orcid.org/0000-0002-0997-3365","https://orcid.org/0009-0007-5974-0635"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"TAKASHI FUJII","raw_affiliation_strings":["Exploratory Research Laboratories, Fujisawa Pharmaceutical Co., Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Exploratory Research Laboratories, Fujisawa Pharmaceutical Co., Ltd","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4590,"currency":"USD","value_usd":4590},"apc_paid":null,"fwci":0.4639,"has_fulltext":true,"cited_by_count":8,"citation_normalized_percentile":{"value":0.56629834,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":94},"biblio":{"volume":"57","issue":"4","first_page":"260","last_page":"263"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10252","display_name":"Microbial Natural Products and Biosynthesis","score":0.6884999871253967,"subfield":{"id":"https://openalex.org/subfields/2402","display_name":"Applied Microbiology and Biotechnology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10252","display_name":"Microbial Natural Products and Biosynthesis","score":0.6884999871253967,"subfield":{"id":"https://openalex.org/subfields/2402","display_name":"Applied Microbiology and Biotechnology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13736","display_name":"Steroid Chemistry and Biochemistry","score":0.15139999985694885,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":0.14380000531673431,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fungal-secondary-metabolites","display_name":"fungal secondary metabolites","score":0.7260000109672546},{"id":"https://openalex.org/keywords/cholesterol-synthesis-inhibitors","display_name":"cholesterol biosynthesis inhibitors","score":0.925000011920929},{"id":"https://openalex.org/keywords/sterol-biosynthesis","display_name":"sterol biosynthesis","score":0.5820000171661377},{"id":"https://openalex.org/keywords/hepg2-cells","display_name":"HepG2 cells","score":0.9229999780654907},{"id":"https://openalex.org/keywords/lipid-lowering-effect","display_name":"hypolipidemic effect","score":0.7919999957084656},{"id":"https://openalex.org/keywords/serum-cholesterol-lowering","display_name":"serum cholesterol lowering","score":0.7710000276565552}],"concepts":[{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.7180459499359131},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.7133738994598389},{"id":"https://openalex.org/C2778718757","wikidata":"https://www.wikidata.org/wiki/Q143623","display_name":"Sterol","level":3,"score":0.5957128405570984},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.5062441229820251},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.5045996904373169},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.46476683020591736},{"id":"https://openalex.org/C116073593","wikidata":"https://www.wikidata.org/wiki/Q864491","display_name":"Biological activity","level":3,"score":0.4517190456390381},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.43603426218032837},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.43531090021133423},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3816036581993103},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.37390977144241333},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000924","descriptor_name":"Anticholesteremic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001203","descriptor_name":"Ascomycota","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D002784","descriptor_name":"Cholesterol","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D002784","descriptor_name":"Cholesterol","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D002784","descriptor_name":"Cholesterol","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D002784","descriptor_name":"Cholesterol","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011817","descriptor_name":"Rabbits","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011973","descriptor_name":"Receptors, LDL","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015854","descriptor_name":"Up-Regulation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.7164/antibiotics.57.260","doi":"https://doi.org/10.7164/antibiotics.57.260","is_oa":true,"landing_page_url":"https://doi.org/10.7164/antibiotics.57.260","pdf_url":"https://www.jstage.jst.go.jp/article/antibiotics1968/57/4/57_4_260/_pdf","source":{"id":"https://openalex.org/S154771817","display_name":"The Journal of Antibiotics","issn_l":"0021-8820","issn":["0021-8820","1881-1469"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Antibiotics","raw_type":"journal-article"},{"id":"pmid:15217190","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15217190","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of antibiotics","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.7164/antibiotics.57.260","doi":"https://doi.org/10.7164/antibiotics.57.260","is_oa":true,"landing_page_url":"https://doi.org/10.7164/antibiotics.57.260","pdf_url":"https://www.jstage.jst.go.jp/article/antibiotics1968/57/4/57_4_260/_pdf","source":{"id":"https://openalex.org/S154771817","display_name":"The Journal of Antibiotics","issn_l":"0021-8820","issn":["0021-8820","1881-1469"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Antibiotics","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2152306751.pdf","grobid_xml":"https://content.openalex.org/works/W2152306751.grobid-xml"},"referenced_works_count":6,"referenced_works":["https://openalex.org/W1489432928","https://openalex.org/W1568755186","https://openalex.org/W1944321556","https://openalex.org/W2008788533","https://openalex.org/W2051792271","https://openalex.org/W2084744450"],"related_works":["https://openalex.org/W2952269826","https://openalex.org/W2131742310","https://openalex.org/W2953290807","https://openalex.org/W2313931924","https://openalex.org/W2022187725","https://openalex.org/W2049056559","https://openalex.org/W2183162634","https://openalex.org/W2239770491","https://openalex.org/W1975515772","https://openalex.org/W2036479646"],"abstract_inverted_index":{"Novel":[0],"cholesterol":[1,22,59],"synthesis":[2,23,46],"inhibitors":[3],"FR171456":[4,18,40,50],"and":[5,24],"FR173945":[6],"were":[7],"isolated":[8],"from":[9],"the":[10,21,26],"culture":[11],"broth":[12],"of":[13,39],"Sporormiella":[14],"minima":[15],"No.":[16],"15604.":[17],"strongly":[19],"inhibited":[20,41],"up-regulated":[25],"LDL-receptor":[27],"expression":[28],"in":[29,42,47,57],"human":[30],"hepatoma":[31],"cell":[32],"line":[33],"Hep":[34],"G2.":[35],"Single":[36],"oral":[37],"administration":[38],"vivo":[43],"hepatic":[44],"sterol":[45],"rats.":[48],"And":[49],"shows":[51],"a":[52,58],"significant":[53],"serum":[54],"cholesterol-lowering":[55],"effect":[56],"fed":[60],"rabbit":[61],"model.":[62]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}